


Searching News Database: CRBSI
HSMN NewsFeed - 18 Jul 2016
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok(TM) Phase 3 Trials
HSMN NewsFeed - 27 Sep 2010
Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
HSMN NewsFeed - 24 Jan 2008
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
HSMN NewsFeed - 11 Jan 2007
Ash Access Technology, Inc. Appoints Dr. Al Guillem as Vice President, Scientific and Quality Affairs
Ash Access Technology, Inc. Appoints Dr. Al Guillem as Vice President, Scientific and Quality Affairs
Additional items found! 3
Members Archive contains
3 additional stories matching:
CRBSI
(Password required)
CRBSI
(Password required)
